PT Enseval Putera Megatrading Tbk. (EPMT.JK)
IDR 2360.0
(0.0%)
IDR 2360.0
(0.0%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 1081.16 Billion IDR | -14.6% |
| 2022 | 1281.12 Billion IDR | 2.2% |
| 2021 | 1273.91 Billion IDR | 24.33% |
| 2020 | 1047.27 Billion IDR | 6.36% |
| 2019 | 935.65 Billion IDR | -7.07% |
| 2018 | 962.1 Billion IDR | 24.27% |
| 2017 | 765.13 Billion IDR | -8.34% |
| 2016 | 883.13 Billion IDR | 1.44% |
| 2015 | 866.45 Billion IDR | 10.69% |
| 2014 | 782.77 Billion IDR | 9.8% |
| 2013 | 732.03 Billion IDR | 15.48% |
| 2012 | 629.84 Billion IDR | 14.8% |
| 2011 | 539.86 Billion IDR | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q3 | 288.57 Billion IDR | 94.5% |
| 2024 Q1 | 391.22 Billion IDR | 68.18% |
| 2024 Q2 | 172.19 Billion IDR | -57.53% |
| 2023 Q3 | 297.68 Billion IDR | 99.02% |
| 2023 FY | - IDR | -14.6% |
| 2023 Q1 | 389.72 Billion IDR | 46.55% |
| 2023 Q2 | 149.57 Billion IDR | -61.62% |
| 2023 Q4 | 236.8 Billion IDR | -20.45% |
| 2022 Q1 | 384.31 Billion IDR | 52.51% |
| 2022 FY | - IDR | 2.2% |
| 2022 Q4 | 265.94 Billion IDR | -25.87% |
| 2022 Q3 | 358.74 Billion IDR | 44.44% |
| 2022 Q2 | 248.36 Billion IDR | -35.37% |
| 2021 Q3 | 357.35 Billion IDR | 27.23% |
| 2021 Q2 | 280.87 Billion IDR | -17.42% |
| 2021 Q4 | 251.99 Billion IDR | -29.48% |
| 2021 Q1 | 340.11 Billion IDR | 18.12% |
| 2021 FY | - IDR | 24.33% |
| 2020 Q1 | 250.34 Billion IDR | 20.08% |
| 2020 FY | - IDR | 6.36% |
| 2020 Q2 | 250.66 Billion IDR | 0.13% |
| 2020 Q3 | 200.58 Billion IDR | -19.98% |
| 2020 Q4 | 287.95 Billion IDR | 43.56% |
| 2019 FY | - IDR | -7.07% |
| 2019 Q3 | 230.42 Billion IDR | -16.55% |
| 2019 Q4 | 208.47 Billion IDR | -9.53% |
| 2019 Q1 | 215.33 Billion IDR | -21.27% |
| 2019 Q2 | 276.11 Billion IDR | 28.23% |
| 2018 Q2 | 256.09 Billion IDR | 32.49% |
| 2018 Q1 | 193.28 Billion IDR | -27.09% |
| 2018 Q4 | 273.5 Billion IDR | -1.71% |
| 2018 FY | - IDR | 24.27% |
| 2018 Q3 | 278.27 Billion IDR | 8.66% |
| 2017 Q2 | 228.91 Billion IDR | 45.86% |
| 2017 FY | - IDR | -8.34% |
| 2017 Q4 | 265.1 Billion IDR | 71.4% |
| 2017 Q3 | 154.67 Billion IDR | -32.43% |
| 2017 Q1 | 156.94 Billion IDR | -42.97% |
| 2016 Q4 | 275.17 Billion IDR | 51.7% |
| 2016 FY | - IDR | 1.44% |
| 2016 Q3 | 181.39 Billion IDR | -16.79% |
| 2016 Q2 | 217.99 Billion IDR | 6.66% |
| 2016 Q1 | 204.38 Billion IDR | -16.67% |
| 2015 FY | - IDR | 10.69% |
| 2015 Q4 | 245.28 Billion IDR | -1.95% |
| 2015 Q3 | 250.15 Billion IDR | 19.37% |
| 2015 Q2 | 209.56 Billion IDR | 29.8% |
| 2015 Q1 | 161.44 Billion IDR | -29.52% |
| 2014 FY | - IDR | 9.8% |
| 2014 Q4 | 229.05 Billion IDR | 13.18% |
| 2014 Q3 | 202.37 Billion IDR | -0.14% |
| 2014 Q2 | 202.65 Billion IDR | 36.3% |
| 2014 Q1 | 148.68 Billion IDR | -41.02% |
| 2013 Q4 | 252.07 Billion IDR | 104.93% |
| 2013 FY | - IDR | 15.48% |
| 2013 Q1 | 129.94 Billion IDR | -44.11% |
| 2013 Q2 | 207.87 Billion IDR | 59.96% |
| 2013 Q3 | 123 Billion IDR | -40.83% |
| 2012 Q1 | 120.37 Billion IDR | 0.0% |
| 2012 FY | - IDR | 14.8% |
| 2012 Q3 | 141.25 Billion IDR | 14.68% |
| 2012 Q4 | 232.52 Billion IDR | 64.62% |
| 2012 Q2 | 123.17 Billion IDR | 2.32% |
| 2011 FY | - IDR | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| PT Itama Ranoraya Tbk | 32.71 Billion IDR | -3204.632% |
| PT Kimia Farma (Persero) Tbk | -1223.64 Billion IDR | 188.356% |
| PT Millennium Pharmacon International Tbk | 124.5 Billion IDR | -768.352% |
| PT Soho Global Health Tbk | 538.94 Billion IDR | -100.608% |